Back to search resultsSummaryRMgm-4602
|
||||||||
*RMgm-4602| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene mutation |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 30941868 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | 8417HP |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Pace T, Ponzi M, Olivieri A |
| Name Group/Department | Dipartimento di Malattie Infettive |
| Name Institute | Istituto Superiore di Sanità |
| City | Rome |
| Country | Italy |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-4602 |
| Principal name | SUB1/asex |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | Not different from wild type |
| Gametocyte/Gamete | Normal gametocyte production. Significant reduction in male gamete formation (exflagellation). The proportion of non-released male gametes (inside PVM/red blood cells) after activation was significantly higher in the SUB1/asex line compared to wt parasites. In addition, the proportion of non-released male gametes still possessing an intact PVM was significantly higher in the SUB1/asex line than in the wt parasites. |
| Fertilization and ookinete | Not tested |
| Oocyst | Not tested |
| Sporozoite | Not tested |
| Liver stage | Not tested |
| Additional remarks phenotype | Mutant/mutation Protein (function) Phenotype 'The SUB1/asex line was characterized by IFA and western blot analysis. In both cases, PbSUB1 was found to be expressed in transgenic schizonts in a similar manner to wt parasites, while it was not detected in SUB1/asex gametocytes'. |
Mutated: Mutant parasite with a mutated gene| top of page | |||||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_1107100 | ||||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0507500 | ||||||||||||||||||||||||||
| Gene product | subtilisin-like protease 1 | ||||||||||||||||||||||||||
| Gene product: Alternative name | SUB1 | ||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||||
| Short description of the mutation | 'promoter swap mutant': the promoter of sub1 replaced with the ama1 promoter (PBANKA_0915000). | ||||||||||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||||||||||
| Short description of the conditional mutagenesis | Not available | ||||||||||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||||||||||
| Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
| Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||||
| Additional remarks genetic modification | To produce the Sub1/asex construct, a gene targeting construct was made by modifying the plasmid pL1313 designed for targeted gene disruption by double cross-over homologous recombination [29]. A 956 bp 5′-targeting region and a 1006 bp 3′ targeting region were amplified from P. berghei genomic DNA using primer pairs sub1-swap-L and sub1-swap-R and cloned into the pL1313 plasmid digested with KpnI-HindIII and NcoI-SacII respectively. The 5’-targeting region includes a DNA sequence upstream of pbsub1 start codon (-1420 bp to -477), while the 3′ targeting region includes part of the coding sequence (-107 bp to +881 bp from pbsub1start codon). The coding region was sequenced with the primers SUB1_seq1 and SUB1_seq2 to confirm that no mutations were introduced during the amplification process. The AMA1 promoter, amplified by genomic DNA with the primer pairs sub1-swap-prAMA1, was then cloned into the resulting plasmid digested with EcoRV/BamHI | ||||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||